Identification of a new potential mechanism responsible for severe bleeding in myeloma: immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant

Haematologica. 2016 Oct;101(10):e423-e426. doi: 10.3324/haematol.2016.144873. Epub 2016 Jun 16.
No abstract available

Keywords: bleeding; immunoglobin; myeloma; protamine sulfate; thrombin time.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anticoagulants / chemistry
  • Anticoagulants / metabolism
  • Antithrombin III / chemistry
  • Antithrombin III / metabolism*
  • Binding Sites / physiology
  • Factor VIIa / chemistry
  • Factor VIIa / metabolism
  • Female
  • Hemorrhage / diagnosis
  • Hemorrhage / etiology
  • Hemorrhage / metabolism*
  • Heparin / chemistry
  • Heparin / metabolism*
  • Humans
  • Immunoglobulin G / chemistry
  • Immunoglobulin G / metabolism*
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / metabolism*
  • Protein Structure, Secondary
  • Severity of Illness Index

Substances

  • Anticoagulants
  • Immunoglobulin G
  • Antithrombin III
  • Heparin
  • Factor VIIa